EXAGEN INC.
XGN
DELAYED 1 MONTH

3 insider filings · Latest: Mar 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 4 8:00 PMJohn AballiDirector, President and CEO
Sale
15,698$3.62$56.8K687,299(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 16 11:17 PMJeffrey G. BlackChief Financial Officer
Grant/Award
50,000$3.1660,000(D)

View →

Mar 12, 2026Mar 16 11:16 PMJohn AballiDirector, President and CEO
Grant/Award
100,000$3.16175,000(D)

View →